Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer

Abstract

The cancer stem cell (CSC) state and epithelial-mesenchymal transition (EMT) activation are tightly interconnected. Cancer cells that acquire the EMT/CSC phenotype are equipped with adaptive metabolic changes to maintain low reactive oxygen species levels and stemness, enhanced drug transporters, anti-apoptotic machinery and DNA repair system. Factors present in the tumor microenvironment such as hypoxia and the communication with non-cancer stromal cells also promote cancer cells to enter the EMT/CSC state and display related resistance. ATP, particularly the high levels of intratumoral extracellular ATP functioning through both signaling pathways and ATP internalization, induces and regulates EMT and CSC. The three of them work together to enhance drug resistance. New findings in each of these factors will help us explore deeper into mechanisms of drug resistance and suggest new resistance-associated markers and therapeutic targets.

Keywords

Tumor microenvironment / macropinocytosis / ATP internalization / ABC transporters / biological markers / apoptosis

References

[1] Pellegatti P,Bianchi G,Pistoia V.Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase.PLoS One2008;3:e2599 PMCID:PMC2440522

[2] Wilhelm K,Müller T.Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.Nat Med2010;16:1434-8

[3] Michaud M,Sukkurwala AQ.Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.Science2011;334:1573-7

[4] Falzoni S,Di Virgilio F.Detecting adenosine triphosphate in the pericellular space.Interface Focus2013;3:20120101 PMCID:PMC3638417

[5] Morciano G,Marchi S.Use of luciferase probes to measure ATP in living cells and animals.Nat Protoc2017;12:1542-62

[6] Liu Y,Cao Y,Bergmeier S.Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms.Cancer Lett2010;298:176-85

[7] Liu Y,Zhang W.A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.Mol Cancer Ther2012;11:1672-82

[8] Qian Y,Liu Y.Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells.Cancer Lett2014;351:242-51

[9] Qian Y,Li Y,Chen X.Extracellular ATP a new player in cancer metabolism: NSCLC cells internalize ATP in vitro and in vivo using multiple endocytic mechanisms.Mol Cancer Res2016;14:1087-96

[10] Wang X,Qian Y.Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase.Oncotarget2017;8:87860-77 PMCID:PMC5675678

[11] Wang X,Chen X.Drug resistance and combating drug resistance in cancer.Cancer Drug Resist2019;2:141-60

[12] Cao Y,Li Y,Zhang H.Extracellular and macropinocytosis internalized ATP work together to induce epithelial-mesenchymal transition and other early metastatic activities in lung cancer.Cancer Cell Int2019;19:254 PMCID:PMC6771108

[13] Najafi M,Majidpoor J.Cancer stem cell (CSC) resistance drivers.Life Sci2019;234:116781

[14] Begicevic RR.ABC transporters in cancer stem cells: beyond chemoresistance.Int J Mol Sci2017;18:2362 PMCID:PMC5713331

[15] Cazet AS,Elsworth BL.Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.Nat Commun2018;9:2897 PMCID:PMC6057940

[16] Mondal S,Mandal C.Nutritional stress reprograms dedifferention in glioblastoma multiforme driven by PTEN/Wnt/Hedgehog axis: a stochastic model of cancer stem cells.Cell Death Discov2018;4:110 PMCID:PMC6281623

[17] Filipponi D,Muller J,Nichols J.DNA damage signaling-induced cancer cell reprogramming as a driver of tumor relapse.Mol Cell2019;74:651-63.e8

[18] D'Alterio C,Sozzi G,Bertolini G.Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion.Semin Cancer Biol2020;60:351-61

[19] Lytle NK,Rajbhandari N.A multiscale map of the stem cell state in pancreatic adenocarcinoma.Cell2019;177:572-86.e22 PMCID:PMC6711371

[20] Visvader JE.Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.Nat Rev Cancer2008;8:755-68

[21] Michor F.The origins and implications of intratumor heterogeneity.Cancer Prev Res (Phila)2010;3:1361-4 PMCID:PMC3633425

[22] Meacham CE.Tumour heterogeneity and cancer cell plasticity.Nature2013;501:328-37 PMCID:PMC4521623

[23] Ma S,Zheng BJ,Guan XY.CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.Oncogene2008;27:1749-58

[24] Mueller MT,Witthauer J.Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.Gastroenterology2009;137:1102-13

[25] Batlle E.Cancer stem cells revisited.Nat Med2017;23:1124-34

[26] Gupta PB,Jiang G.Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.Cell2011;146:633-44

[27] Dirkse A,Buder T.Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.Nat Commun2019;10:1787 PMCID:PMC6467886

[28] Peixoto J.Metabolic traits of cancer stem cells.Dis Model Mech2018;11:dmm033464 PMCID:PMC6124552

[29] Dean M,Chimini G.The human ATP-binding cassette (ABC) transporter superfamily.J Lipid Res2001;42:1007-17

[30] Li YJ,Yao N.Autophagy and multidrug resistance in cancer.Chin J Cancer2017;36:52 PMCID:PMC5482965

[31] Kadioglu O,Munder M,Greten HJ.Effect of ABC transporter expression and mutational status on survival rates of cancer patients.Biomed Pharmacother2020;131:110718

[32] Hu J,Yue X.Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.Oncotarget2017;8:28463-70 PMCID:PMC5438664

[33] Robey RW,Hall MD,Bates SE.Revisiting the role of ABC transporters in multidrug-resistant cancer.Nat Rev Cancer2018;18:452-64 PMCID:PMC6622180

[34] Patrawala L,Schneider-Broussard R,Claypool K.Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.Cancer Res2005;65:6207-19

[35] Ling X,Fan C.An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.J Exp Clin Cancer Res2018;37:240 PMCID:PMC6169080

[36] Keshet GI,Itzhaki O.MDR1 expression identifies human melanoma stem cells.Biochem Biophys Res Commun2008;368:930-6

[37] Gong F,Zhang T.Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.Eur J Pharmacol2019;853:345-52

[38] Xu H,Li W.SMAR1 attenuates the stemness of osteosarcoma cells via through suppressing ABCG2 transcriptional activity.Environ Toxicol2021;36:1090-8

[39] Stefan SM.Multi-target ABC transporter modulators: what next and where to go?.Future Med Chem2019;11:2353-8

[40] Chefetz I,Yang K.A pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells.Cell Rep2019;26:3061-75.e6 PMCID:PMC7061440

[41] Mazor G,Picard D.The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.Cell Death Dis2019;10:246 PMCID:PMC6416247

[42] Cojoc M,Muders MH.A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.Semin Cancer Biol2015;31:16-27

[43] Li Y,Zhu J,Jiang H.High ALDH activity defines ovarian cancer stem-like cells with enhanced invasiveness and EMT progress which are responsible for tumor invasion.Biochem Biophys Res Commun2018;495:1081-8

[44] Singh S,Koppaka V.Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.Free Radic Biol Med2013;56:89-101 PMCID:PMC3631350

[45] Kim D,Ryoo IG.High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.Cell Death Dis2018;9:896 PMCID:PMC6117306

[46] Harati M, Rodemann HP, Toulany M. Nanog signaling mediates radioresistance in ALDH-positive breast cancer cells.Int J Mol Sci2019;20:1151 PMCID:PMC6429380

[47] Muralikrishnan V,Nephew KP.Targeting aldehyde dehydrogenases to eliminate cancer stem cells in gynecologic malignancies.Cancers (Basel)2020;12:961 PMCID:PMC7225959

[48] Chatterjee R.ROS and oncogenesis with special reference to EMT and stemness.Eur J Cell Biol2020;99:151073

[49] Diehn M,Lobo NA.Association of reactive oxygen species levels and radioresistance in cancer stem cells.Nature2009;458:780-3 PMCID:PMC2778612

[50] Qian X,Yao W.Reactive oxygen species in cancer stem cells of head and neck squamous cancer.Semin Cancer Biol2018;53:248-57

[51] Park HK,Oh YT.Interplay between TRAP1 and Sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells.Cancer Res2019;79:1369-82

[52] Wu MJ,Kim MR.Epithelial-mesenchymal transition directs stem cell polarity via regulation of mitofusin.Cell Metab2019;29:993-1002.e6

[53] Huang H,Ideta T,Ellis LM.Inhibition of PGE₂/EP4 receptor signaling enhances oxaliplatin efficacy in resistant colon cancer cells through modulation of oxidative stress.Sci Rep2019;9:4954 PMCID:PMC6427013

[54] Meng Q,Liang C.Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.Oncogene2018;37:5843-57

[55] Redza-Dutordoir M.Activation of apoptosis signalling pathways by reactive oxygen species.Biochim Biophys Acta2016;1863:2977-92

[56] Townsend DM.The role of glutathione-S-transferase in anti-cancer drug resistance.Oncogene2003;22:7369-75 PMCID:PMC6361125

[57] Lu H,Xiang L.Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype.Proc Natl Acad Sci U S A2015;112:E4600-9 PMCID:PMC4547233

[58] Lan D,He R,Bin Y.Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.Am J Transl Res2018;10:1295-309 PMCID:PMC5992547

[59] Akan I,Akca H,Ozben T.Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine.Cancer Cell Int2005;5:22 PMCID:PMC1183228

[60] Bansal A.Glutathione metabolism in cancer progression and treatment resistance.J Cell Biol2018;217:2291-8 PMCID:PMC6028537

[61] Boswell-Casteel RC,Schuetz JD.ABCB6, an ABC transporter impacting drug response and disease.AAPS J2017;20:8 PMCID:PMC5821141

[62] Tong X,Zhang Y,Wang X.Expression levels of MRP1, GST-π, and GSK3β in ovarian cancer and the relationship with drug resistance and prognosis of patients.Oncol Lett2019;18:22-8 PMCID:PMC6540457

[63] Wang B,Li Y.Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.Onco Targets Ther2019;12:5751-65 PMCID:PMC6645696

[64] El-Readi MZ,Abdelghany AA,Efferth T.Resveratrol mediated cancer cell apoptosis, and modulation of multidrug resistance proteins and metabolic enzymes.Phytomedicine2019;55:269-81

[65] Chatterjee A.The multifaceted role of glutathione S-transferases in cancer.Cancer Lett2018;433:33-42

[66] Yoshida GJ.Metabolic reprogramming: the emerging concept and associated therapeutic strategies.J Exp Clin Cancer Res2015;34:111 PMCID:PMC4595070

[67] El-Sahli S.Cancer stem cell-associated pathways in the metabolic reprogramming of breast cancer.Int J Mol Sci2020;21:9125 PMCID:PMC7730588

[68] Fonseca NA,Moura V,Moreira JN.The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors.Crit Rev Oncol Hematol2017;113:111-21

[69] Luo M,Brooks MD.Targeting breast cancer stem cell state equilibrium through modulation of redox signaling.Cell Metab2018;28:69-86.e6 PMCID:PMC6037414

[70] Shibue T.EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.Nat Rev Clin Oncol2017;14:611-29 PMCID:PMC5720366

[71] Dhawan A,Taube JH.Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia.Sci Rep2016;6:18074 PMCID:PMC4738268

[72] Emami Nejad A,Rostami A.The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment.Cancer Cell Int2021;21:62 PMCID:PMC7816485

[73] Francesco EM, Sotgia F, Lisanti MP. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.Biochem J2018;475:1611-34 PMCID:PMC5941316

[74] Zhao H,Zhang Z.Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells.J Cell Mol Med2017;21:2055-67 PMCID:PMC5571518

[75] Semenza GL.Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype.EMBO J2017;36:252-9 PMCID:PMC5286373

[76] Qiang L,Zhang HW.HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway.Cell Death Differ2012;19:284-94 PMCID:PMC3263503

[77] Yeo CD,Choi SY.The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation.Korean J Intern Med2017;32:589-99 PMCID:PMC5511947

[78] Zhang Z,Rong Y,Gong Q.Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α signaling.Am J Cancer Res2021;11:123-37 PMCID:PMC7840708

[79] Schöning JP,Gu W.Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and Hif-2α.Clin Exp Pharmacol Physiol2017;44:153-61

[80] Nilsson MB,Robichaux J.A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components.Sci Transl Med2020;12:eaaz4589

[81] Demaria M,Lebiedzinska M,D’Angeli L.A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction.Aging2010;2:823-42 PMCID:PMC3006025

[82] Folmes CD,Faustino RS.Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.J Cardiovasc Transl Res2013;6:10-21 PMCID:PMC3750736

[83] Das PK,Rakib MA.Plasticity of cancer stem cell: origin and role in disease progression and therapy resistance.Stem Cell Rev Rep2020;16:397-412

[84] Hirpara J,Tan JKM.Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance.Redox Biol2019;25:101076 PMCID:PMC6859574

[85] Dar S,Mert I.Bioenergetic adaptations in chemoresistant ovarian cancer cells.Sci Rep2017;7:8760 PMCID:PMC5562731

[86] Onnis B,Melillo G.Development of HIF-1 inhibitors for cancer therapy.J Cell Mol Med2009;13:2780-6 PMCID:PMC2832082

[87] Zhou Y,Shingu T.Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis.J Biol Chem2011;286:32843-53 PMCID:PMC3173179

[88] Schornack PA.Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors.Neoplasia2003;5:135-45 PMCID:PMC1502399

[89] Corbet C.Tumour acidosis: from the passenger to the driver's seat.Nat Rev Cancer2017;17:577-93

[90] Riemann A,Gießelmann M,Haupt V.Extracellular acidosis modulates the expression of Epithelial-Mesenchymal Transition (EMT) markers and adhesion of epithelial and tumor cells.Neoplasia2019;21:450-8 PMCID:PMC6447725

[91] Linden C, Corbet C. Therapeutic targeting of cancer stem cells: integrating and exploiting the acidic niche.Front Oncol2019;9:159 PMCID:PMC6433943

[92] Andreucci E,Ruzzolini J.The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells.J Mol Med (Berl)2020;98:1431-46 PMCID:PMC7525286

[93] Ruzzolini J,Andreucci E.Everolimus selectively targets vemurafenib resistant BRAF^V600E melanoma cells adapted to low pH.Cancer Lett2017;408:43-54

[94] Li Z,Wu Q.Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.Cancer Cell2009;15:501-13 PMCID:PMC2693960

[95] Khacho M,Patten D.Acidosis overrides oxygen deprivation to maintain mitochondrial function and cell survival.Nat Commun2014;5:3550 PMCID:PMC3988820

[96] Corbet C,Santiago de Jesus JP.TGF-β2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells.Nat Commun2020;11:454 PMCID:PMC6978517

[97] Li J,Thomes-Pepin J.Lipid Desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells.Cell Stem Cell2017;20:303-314.e5 PMCID:PMC5337165

[98] Thews O,Sauvant C.Hypoxia-induced extracellular acidosis increases p-glycoprotein activity and chemoresistance in tumors in vivo via p38 signaling pathway.Adv Exp Med Biol2011;701:115-22

[99] Cheng GM.Adverse cell culture conditions mimicking the tumor microenvironment upregulate ABCG2 to mediate multidrug resistance and a more malignant phenotype.ISRN Oncol2012;2012:746025 PMCID:PMC3384895

[100] Smith AG.Autophagy, cancer stem cells and drug resistance.J Pathol2019;247:708-18 PMCID:PMC6668344

[101] Kanamala M,Yang M,Wu Z.Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.Biomaterials2016;85:152-67

[102] Corbet C,Pourcelle V.Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.J Control Release2016;223:53-63

[103] Fitzwalter BE,Sullivan KD.Autophagy inhibition mediates apoptosis sensitization in cancer therapy by relieving FOXO3a turnover.Dev Cell2018;44:555-65.e3 PMCID:PMC5866042

[104] Liang C,Cai X.Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma.Cell Death Dis2020;11:1017 PMCID:PMC7701149

[105] Ho CJ.Molecular mechanisms underlying autophagy-mediated treatment resistance in cancer.Cancers (Basel)2019;11:1775 PMCID:PMC6896088

[106] Ryoo IG,Ku SK.High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.Redox Biol2018;17:246-58 PMCID:PMC6006726

[107] Jang JE,Jeung HK.PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells.J Exp Clin Cancer Res2020;39:66 PMCID:PMC7158163

[108] Yao N,Hu N.Inhibition of PINK1/Parkin-dependent mitophagy sensitizes multidrug-resistant cancer cells to B5G1, a new betulinic acid analog.Cell Death Dis2019;10:232 PMCID:PMC6408511

[109] Yan C.Dual role of mitophagy in cancer drug resistance.Anticancer Res2018;38:617-21

[110] Liu K,Kim JY.Mitophagy controls the activities of tumor suppressor p53 to regulate hepatic cancer stem cells.Mol Cell2017;68:281-92.e5 PMCID:PMC5687282

[111] Yan C,Guo CY.Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells.Cancer Lett2017;388:34-42

[112] Tam SY,Law HKW.Hypoxia-induced epithelial-mesenchymal transition in cancers: HIF-1α and beyond.Front Oncol2020;10:486 PMCID:PMC7156534

[113] Gjorevski N,Nelson CM.Regulation of epithelial-mesenchymal transition by transmission of mechanical stress through epithelial tissues.Cancer Microenviron2012;5:29-38 PMCID:PMC3343202

[114] Suarez-Carmona M,Cataldo D.EMT and inflammation: inseparable actors of cancer progression.Mol Oncol2017;11:805-23 PMCID:PMC5496491

[115] Du B.Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer.Molecules2016;21:965 PMCID:PMC6273543

[116] Jolly MK,Sheth M.Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.Pharmacol Ther2019;194:161-84

[117] Bocci F,Boareto M.Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.Proc Natl Acad Sci U S A2019;116:148-57 PMCID:PMC6320545

[118] Wilson MM,Lees JA.Emerging mechanisms by which EMT programs control stemness.Trends Cancer2020;6:775-80

[119] Wang Z,Provaznik J,Zöller M.Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.J Exp Clin Cancer Res2019;38:132 PMCID:PMC6425561

[120] Schuster N.Mechanisms of TGF-beta-mediated apoptosis.Cell Tissue Res2002;307:1-14

[121] Singh A.EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.Oncogene2010;29:4741-51 PMCID:PMC3176718

[122] Tripathi V,Stuelten CH.TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance.Oncogene2019;38:3185-200 PMCID:PMC6486402

[123] Xu X,He X.TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.Biochem Biophys Res Commun2018;502:160-5

[124] Chaffer CL,Lee T.Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.Cell2013;154:61-74 PMCID:PMC4015106

[125] Oshimori N,Fuchs E.TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma.Cell2015;160:963-76 PMCID:PMC4509607

[126] Zhu X,Liu L.EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies.Front Oncol2019;9:1044 PMCID:PMC6798878

[127] Saxena M,Pathak H.Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.Cell Death Dis2011;2:e179 PMCID:PMC3199722

[128] Dong J,Sun W,Cheng H.Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.PLoS One2017;12:e0185088 PMCID:PMC5608310

[129] Xu W,Lu N.A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition.Cell Adh Migr2015;9:317-24 PMCID:PMC4594353

[130] Karaosmanoğlu O,Sivas H.Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.Cell Oncol (Dordr)2018;41:439-53

[131] Roh YG,Jeong MS.Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1.BMB Rep2018;51:98-103 PMCID:PMC5836564

[132] Yochum ZA,Wang H.Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.Oncogene2019;38:656-70 PMCID:PMC6358506

[133] Paranjape AN,Werden SJ.Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.Oncogene2016;35:5963-76 PMCID:PMC5116559

[134] Sun S,Qin X.TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.Protoplasma2020;257:921-30

[135] Zhang P,Ma L.ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance.Cell Cycle2015;14:481-7 PMCID:PMC4614883

[136] Zhang X,Zhang Q.ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.Cell Death Dis2018;9:57 PMCID:PMC5833408

[137] Zhang P,Wang L.ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.Nat Cell Biol2014;16:864-75 PMCID:PMC4150825

[138] Espinoza I.Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.Cancer Lett2013;341:41-5

[139] Poh ME,Rajadurai P.Epithelial-to-mesenchymal transition (EMT) causing acquired resistance to afatinib in a patient with epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma.J Thorac Dis2018;10:E560-3 PMCID:PMC6105946

[140] Namba K,Takahashi Y.Activation of AXL as a preclinical acquired resistance mechanism against osimertinib treatment in EGFR-mutant non-small cell lung cancer cells.Mol Cancer Res2019;17:499-507

[141] Zhou J,Zeng Y,Hu Q.Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.Oncotarget2015;6:44332-45 PMCID:PMC4792560

[142] Sato H,Sakaguchi M.Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.Cancer Sci2018;109:3183-96 PMCID:PMC6172047

[143] Otsuki Y,Arima Y.Prospects for new lung cancer treatments that target EMT signaling.Dev Dyn2018;247:462-72

[144] Cho ES,Kim NH.Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).Arch Pharm Res2019;42:14-24

[145] Wu X,Zhou X.SphK1 functions downstream of IGF-1 to modulate IGF-1-induced EMT, migration and paclitaxel resistance of A549 cells: A preliminary in vitro study.J Cancer2019;10:4264-9 PMCID:PMC6691691

[146] May CD,Evans KW,Guo W.Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.Breast Cancer Res2011;13:202 PMCID:PMC3109556

[147] Jabbarzadeh Kaboli P,Aghapour S.Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer - a comprehensive review from chemotherapy to immunotherapy.Pharmacol Res2020;156:104806

[148] Zhang Z,Rong Y.Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.J Exp Clin Cancer Res2018;37:291 PMCID:PMC6263055

[149] Mohapatra P,Mohanty S.CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.JCI Insight2021;6:143643 PMCID:PMC7934946

[150] Yuan Z,Zhan Y.Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer.Br J Cancer2020;122:1342-53 PMCID:PMC7188877

[151] Takebe N,Warren RQ.Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.Nat Rev Clin Oncol2011;8:97-106

[152] Gu JW,Pannuti A,Osborne B.Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy.Vasc Cell2012;4:7 PMCID:PMC3348040

[153] Xiao W,Duan Y,Ke Y.Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.J Exp Clin Cancer Res2017;36:41 PMCID:PMC5345133

[154] Lee CW,Prudovsky I.Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.Cancer Res2008;68:5273-81 PMCID:PMC2652573

[155] Huang J,Li J.Notch-1 Confers Chemoresistance in lung adenocarcinoma to taxanes through AP-1/microRNA-451 mediated regulation of MDR-1.Mol Ther Nucleic Acids2016;5:e375 PMCID:PMC5095685

[156] Sun L,He Z.HES1 Promotes colorectal cancer cell resistance to 5-Fu by inducing of EMT and ABC transporter proteins.J Cancer2017;8:2802-8 PMCID:PMC5604212

[157] Hu S,Li T.Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency.Sci Transl Med2017;9:eaag0339

[158] Baker A,Bocchetta M.Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.Oncogene2018;37:4489-504

[159] Yang Z,Liu D,Chen H.Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop.Oncotarget2014;6:5072-87 PMCID:PMC4467134

[160] Usui T,Umata K.Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture.Int J Mol Sci2018;19:1098 PMCID:PMC5979580

[161] Cho Y.Cancer stem cells as a potential target to overcome multidrug resistance.Front Oncol2020;10:764 PMCID:PMC7280434

[162] Zhang H,Cheng M,Hu X.The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.Oncol Rep2020;44:2610-20 PMCID:PMC7640363

[163] Zhou XT,Li HY.Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma.J Cell Mol Med2020;24:4298-311 PMCID:PMC7171417

[164] Po A,Catanzaro G.Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells.Sci Rep2020;10:13988 PMCID:PMC7438531

[165] Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via β-catenin/TCF signaling.Oncol Rep2010;24

[166] Vesel M,Feller D.ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.Respir Res2017;18:52 PMCID:PMC5364604

[167] He L,Zhou S.Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells.Exp Mol Med2018;50:1-12 PMCID:PMC6093888

[168] Fukumoto T,Nacarelli T.N⁶-Methylation of adenosine of FZD10 mRNA contributes to PARP inhibitor resistance.Cancer Res2019;79:2812-20 PMCID:PMC6548690

[169] Yamamoto TM,Watson ZL.Activation of Wnt signaling promotes olaparib resistant ovarian cancer.Mol Carcinog2019;58:1770-82 PMCID:PMC7537108

[170] Zhong Z.Wnt signaling and drug resistance in cancer.Mol Pharmacol2020;97:72-89

[171] Chen G,Gao X.Wnt/β-catenin pathway activation mediates adaptive resistance to BRAF inhibition in colorectal cancer.Mol Cancer Ther2018;17:806-13 PMCID:PMC5882543

[172] Solberg NT,Lund K,Olsen PA.TANKYRASE inhibition enhances the antiproliferative effect of PI3K and EGFR inhibition, mutually affecting β-CATENIN and AKT signaling in colorectal cancer.Mol Cancer Res2018;16:543-53

[173] Park YL,Cho YW.Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.Int J Cancer2019;144:389-401 PMCID:PMC6587482

[174] Lee E,Logan SK.Divergent androgen receptor and beta-catenin signaling in prostate cancer cells.PLoS One2015;10:e0141589 PMCID:PMC4624871

[175] Zhang Z,Li J.Inhibition of the Wnt/β-Catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate cancer.Cancer Res2018;78:3147-62 PMCID:PMC6004251

[176] Takebe N,Harris PJ.Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.Nat Rev Clin Oncol2015;12:445-64 PMCID:PMC4520755

[177] Zhou HM,Zhang X.Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.Signal Transduct Target Ther2021;6:62 PMCID:PMC7884707

[178] Yeh DW,Chen YW,Chuang TH.Interplay between inflammation and stemness in cancer cells: the role of toll-like receptor signaling.J Immunol Res2016;2016:4368101 PMCID:PMC5223024

[179] Qin J,Lu Y.Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression.Sci Rep2017;7:10592 PMCID:PMC5587562

[180] Mohiuddin IS,Kang MH.Role of OCT4 in cancer stem-like cells and chemotherapy resistance.Biochim Biophys Acta Mol Basis Dis2020;1866:165432 PMCID:PMC6754810

[181] Pires BR,Ferreira GM.NF-kappaB is involved in the regulation of EMT genes in breast cancer cells.PLoS One2017;12:e0169622 PMCID:PMC5249109

[182] Zou K,Zhang Y.β-Elemene enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial-mesenchymal transition and cancer stem cell traits via Prx-1/NF-kB/iNOS signaling pathway.Aging (Albany NY)2020;13:2575-92 PMCID:PMC7880315

[183] Li L,Hu M,Chen H.Metformin overcomes acquired resistance to EGFR TKIs in EGFR-Mutant lung cancer via AMPK/ERK/NF-κB signaling pathway.Front Oncol2020;10:1605 PMCID:PMC7511631

[184] Unver N.Macrophage chemoattractants secreted by cancer cells: Sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target.Cytokine Growth Factor Rev2019;50:13-8

[185] Hu YB,Mu L.Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.Oncogene2019;38:1951-65 PMCID:PMC6756234

[186] Bu L,Yasuda T,Ishimoto T.Functional diversity of cancer-associated fibroblasts in modulating drug resistance.Cancer Sci2020;111:3468-77 PMCID:PMC7541012

[187] Hu JL,Lan XL.CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.Mol Cancer2019;18:91 PMCID:PMC6503554

[188] Lv J,Chen FK.M2-like tumor-associated macrophages-secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β-catenin pathway in thyroid cancer.Mol Carcinog2021;60:25-37

[189] Chen Y,Wang C.Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition.Onco Targets Ther2018;11:3817-26 PMCID:PMC6038883

[190] Wang N,Zheng Y.CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.Cell Death Dis2018;9:880 PMCID:PMC6115425

[191] Zhou K,Zhan J.Targeting tumor-associated macrophages in the tumor microenvironment.Oncol Lett2020;20:234 PMCID:PMC7500051

[192] Choi CH.ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.Cancer Cell Int2005;5:30 PMCID:PMC1277830

[193] Nieminen AI,Haikala HM.Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis.Proc Natl Acad Sci U S A2013;110:E1839-48 PMCID:PMC3657814

[194] Sever R.Signal transduction in cancer.Cold Spring Harb Perspect Med2015;5:a006098 PMCID:PMC4382731

[195] Virgilio F. Purines, purinergic receptors, and cancer.Cancer Res2012;72:5441-7

[196] Pecqueur C,Oizel K,Vallette FM.Targeting metabolism to induce cell death in cancer cells and cancer stem cells.Int J Cell Biol2013;2013:805975 PMCID:PMC3583110

[197] Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation.Science2009;324:1029-33 PMCID:PMC2849637

[198] Zhou Y,Chen J.Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells.Cancer Res2012;72:304-14 PMCID:PMC3601736

[199] Soo JS,Tan SH.Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells.Apoptosis2015;20:1373-87

[200] Wang H,Qin Y,Xu B.Nucleopeptide assemblies selectively sequester ATP in cancer cells to increase the efficacy of doxorubicin.Angew Chem2018;130:5025-9 PMCID:PMC6014697

[201] Zheng X,Lambrecht MJ.Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response.Oncotarget2018;9:14741-53 PMCID:PMC5871075

[202] Liu G,Liu J.Engineering of a core-shell nanoplatform to overcome multidrug resistance via ATP deprivation.Adv Healthc Mater2020;9:e2000432

[203] Feng LL,Zhu MC,Wang X.The yin and yang functions of extracellular ATP and adenosine in tumor immunity.Cancer Cell Int2020;20:110 PMCID:PMC7137337

[204] Commisso C,Soydaner-Azeloglu RG.Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.Nature2013;497:633-7 PMCID:PMC3810415

[205] Wang H,Liu X.Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance.Nat Commun2018;9:562 PMCID:PMC5805731

[206] Campos-Contreras ADR,Vázquez-Cuevas FG.Purinergic signaling in the hallmarks of cancer.Cells2020;9:1612 PMCID:PMC7407645

[207] Aroua N,Ghisi M.Extracellular ATP and CD39 activate cAMP-mediated mitochondrial stress response to promote cytarabine resistance in acute myeloid leukemia.Cancer Discov2020;10:1544-65

[208] Li XY,Xiao C.Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity.Cancer Discov2019;9:1754-73 PMCID:PMC6891207

[209] Elaskalani O,Moran N,Metharom P.The role of platelet-derived ADP and ATP in promoting pancreatic cancer cell survival and gemcitabine resistance.Cancers (Basel)2017;9:142 PMCID:PMC5664081

[210] Virgilio F, Adinolfi E. Extracellular purines, purinergic receptors and tumor growth.Oncogene2017;36:293-303 PMCID:PMC5269532

[211] Gilbert SM,Hassan S.ATP in the tumour microenvironment drives expression of nfP2X₇, a key mediator of cancer cell survival.Oncogene2019;38:194-208 PMCID:PMC6328436

[212] Arnaud-Sampaio VF,Ulrich H.The P2X7 receptor in the maintenance of cancer stem cells, chemoresistance and metastasis.Stem Cell Rev Rep2020;16:288-300

[213] Kepp O,Liu P.Extracellular nucleosides and nucleotides as immunomodulators.Immunol Rev2017;280:83-92

[214] Ghiringhelli F,Tesniere A.Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.Nat Med2009;15:1170-8

[215] Galluzzi L,Kepp O,Kroemer G.Immunogenic cell death in cancer and infectious disease.Nat Rev Immunol2017;17:97-111

[216] Ohta A.A Metabolic immune checkpoint: adenosine in tumor microenvironment.Front Immunol2016;7:109 PMCID:PMC4809887

[217] Pietrocola F,Kroemer G.Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells.Cell Cycle2016;15:3327-8 PMCID:PMC5224452

[218] Luo Y,Zhang P.TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy.Theranostics2020;10:6987-7001 PMCID:PMC7295044

[219] Vultaggio-Poma V,Di Virgilio F.Extracellular ATP: a feasible target for cancer therapy.Cells2020;9:2496 PMCID:PMC7698494